It has been reported that both in cancer and embryonic stem cells, β3-ARs promote this metabolic shift, not only inducing the specific glycolytic cytoplasmic enzymes but also promoting the expression of UCP-2 (uncoupling protein-2) responsible for a reduced mitochondrial activity and inhibition of mitochondrial reactive oxygen species production (109). The gene discussed is UCP2; the disease is cancer.